Predict your next investment

MORE Health company logo
INTERNET | Internet Software & Services / Health & Wellness
morehealth.com

See what CB Insights has to offer

Founded Year

2013

Stage

Series D | Alive

Total Raised

$4.42M

Revenue

$0000 

About MORE Health

MORE Health contracts with physicians to provide expert treatment plans, recovery tools, and other services. In order to strengthen MORE Health's overall service quality the company has built a comprehensive network platform that combines, organizes and applies patients' information in numerous aspects; reinforces communication between doctors and patients; and allows many classes of users to access information directly through its network platform. The company also operates in China as Aiyichuandi (爱医传递).

MORE Health Headquarter Location

999 Baker Way Suite 500

Foster City, California, 94404,

United States

888-908-6673

Latest MORE Health News

Amgen, Biogen, Gilead, Merck, Pfizer, and More Health Care Earnings Coming This Week

Jan 31, 2021

January 31, 2021 10:00 am Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. Health care has been a big winner in the wake of the coronavirus, and the sector has largely outpaced the markets. These earnings will help dictate where the sector goes from here. Note that the earnings and revenue estimates may change ahead of the formal reports, and some companies may reschedule reporting dates as well. Here we have what analysts are predicting on the top- and bottom-lines as well as a recent trading history and consensus price target. Pfizer Inc. ( NYSE: PFE ) will share its latest quarterly earnings Tuesday morning. The consensus estimates call for $0.49 in earnings per share (EPS) on $11.43 billion in revenue. Shares traded at $35.90 on Friday’s close, in a 52-week range of $26.45 to $43.08. The consensus price target is $41.49. Amgen Inc. ( NASDAQ: AMGN ) is set to report its most recent results on Tuesday afternoon. The consensus estimates from Refinitiv call for EPS of $3.40 and $6.59 billion in revenue. Shares were changing hands at $241.43 on Friday’s close. The 52-week range is $177.05 to $276.69. Biogen Inc. ( NASDAQ: BIIB ) is scheduled to report its fourth-quarter results on Wednesday morning. The consensus forecast calls for $4.83 in EPS, as well as $2.8 billion in revenue. The stock ended last week at $282.61 per share. The consensus price target is $293.76, and the 52-week range is $223.25 to $374.99. AbbVie Inc. ( NYSE: ABBV ) will post its latest quarterly earnings on Wednesday morning. The consensus estimates call for $2.85 in EPS and $13.7 billion in revenue. Shares were at $102.48 as Friday’s trading ended, in a 52-week range of $62.55 to $113.41. The consensus price target is $117.67. Alexion Pharmaceuticals Inc. ( NASDAQ: ALXN ) is scheduled to report its fourth-quarter results on Thursday before the opening bell. The consensus estimates are $2.56 in EPS and $1.52 billion in revenue. Shares traded at $153.33 as last week came to a close. The consensus price target is $173.65, and the 52-week trading range is $72.67 to $162.60. Merck & Co., Inc. ( NYSE: MRK ) is expected to reveal its fourth-quarter results on Thursday morning. The consensus forecast calls for $1.38 in EPS, as well as $12.67 billion in revenue. The stock ended last week at $77.07 per share. The consensus price target is $96.70, and the 52-week range is $65.25 to $89.20. Bristol-Myers Squibb Co. ( NYSE: BMY ) also will share its latest quarterly earnings first thing Thursday as well. The consensus estimates call for $1.41 in EPS and $10.73 billion in revenue. Shares were at $61.43 as Friday’s trading ended, in a 52-week range of $45.76 to $67.80. The consensus price target is $74.94. Gilead Sciences Inc. ( NASDAQ: GILD ) is expected to reveal its fourth-quarter results on Thursday after the close. The consensus forecast calls for $1.99 in EPS, as well as $6.93 billion in revenue. The stock closed at $65.60 per share. The consensus price target is $73.11, and the 52-week trading range is $56.56 to $85.97. And Regeneron Pharmaceuticals, Inc. ( NASDAQ: REGN ) will share its latest quarterly earnings Friday morning. The consensus estimates call for $8.48 in EPS on $2.44 billion in revenue. Shares traded at $503.84 on Friday’s close, in a 52-week range of $339.39 to $664.64. The consensus price target is $661.44. Get Our Free Investment Newsletter I have read, and agree to the Terms of Use

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing MORE Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned MORE Health in 2 CB Insights research briefs, most recently on Jul 26, 2021.

Expert Collections containing MORE Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MORE Health is included in 6 Expert Collections, including Smart Money VCs (2017-2019).

S

Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

D

Digital Health 150 (2019)

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

H

Healthcare Companies Backed By China's Big Tech

110 items

Baidu, Alibaba, Tencent, and Ping An have collectively invested in 106 unique companies in healthcare.

C

China Digital Health Collection

467 items

D

Digital Health

10,285 items

Companies using/incorporating digital tech into health, wellness, and life science offerings. Includes cos operating within the hc, consumer health, and life science industries + tech vendors catering to them. Excludes cos exclusively focused on fitness/sports & performance

T

Telehealth

2,611 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

MORE Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

MORE Health Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.